in research - Abstract: RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells. Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, August 25, 2010

in research - Abstract: RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells.



CONCLUSIONS: Our data provides kinase targets that could be exploited to design better therapeutics for ovarian cancer patients. We also demonstrate the effectiveness of high-throughput RNAi screening as a tool for identifying sensitizing targets to known and established chemotherapeutic agents.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.